Autonomix Medical, Inc. (AMIX)
Autonomix Medical, Inc. operates in the Medical - Devices industry of the Healthcare sector, headquartered in The Woodlands, TX, US. The stock last traded at $8.63, down 5.37% on the session, giving a market capitalisation of $4.7M. On trailing twelve-month figures it carries a trailing P/E of -0.14, a net margin of 0.0%. Its beta of -1.30 implies it has historically moved less than the broad market.
Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. The company’s technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. It develops technology for patients with pancreatic cancer and addresses indications for chronic pain management, hypertension, cardiovascular, and other nerve-related disorders. Autonomix Medical, Inc. was incorporated in 2014 and is headquartered in The Woodlands, Texas.
Autonomix Medical, Inc. is most often compared with the following Healthcare names: